rhc 3164 has been researched along with calcimycin in 1 studies
| Studies (rhc 3164) | Trials (rhc 3164) | Recent Studies (post-2010) (rhc 3164) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 11,946 | 40 | 444 |
| Protein | Taxonomy | rhc 3164 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dally-Meade, V; Huang, F; Jariwala, N; Khandwala, A | 1 |
1 other study(ies) available for rhc 3164 and calcimycin
| Article | Year |
|---|---|
Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
Topics: Animals; Basophils; Calcimycin; Cromolyn Sodium; Dextrans; Dose-Response Relationship, Drug; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity; Lung; Mast Cells; Phosphatidylserines; Rats; Tachyphylaxis; Time Factors; Triazoles | 1984 |